N-3 polyunsaturated fatty acids and mast cell activation

Journal of Leukocyte Biology

Volumn 97, Issue 5, 2015, Pages 859-871

  Wang, Xiaofeng ^a   Kulka, Marianna ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

DHA; Eicosanoid; EPA; Fc RI; Lipid rafts

Indexed keywords

ARACHIDONIC ACID; CARBOXYPEPTIDASE A; CHYMASE; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; HEPARIN; HISTAMINE; ICOSANOID; ICOSAPENTAENOIC ACID; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LINOLENIC ACID; MAJOR BASIC PROTEIN; OMEGA 3 FATTY ACID; PROSTAGLANDIN D2; PROSTAGLANDIN E; SEROTONIN; THROMBOCYTE ACTIVATING FACTOR; TRYPTASE; TUMOR NECROSIS FACTOR;

ARTICLE; BONE MARROW DERIVED MAST CELL; CELL ACTIVATION; CELL ADHESION; CELL MIGRATION; CELL VIABILITY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; INFLAMMATION; LIPID RAFT; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 84929156538     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.2RU0814-388R     Document Type: Article

References (206)

1. Abraham, S. N., St John, A. L. (2010) Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 10, 440–452.
2. Palker, T. J., Dong, G., Leitner, W. W. (2010) Mast cells in innate and adaptive immunity to infection. Eur. J. Immunol. 40, 13–18.
3. Miller, H. R., Pemberton, A. D. (2002) Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 105, 375–390.
4. Kirshenbaum, A. S., Kessler, S. W., Goff, J. P., Metcalfe, D. D. (1991) Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J. Immunol. 146, 1410–1415.
5. Kambe, N., Hiramatsu, H., Shimonaka, M., Fujino, H., Nishikomori, R., Heike, T., Ito, M., Kobayashi, K., Ueyama, Y., Matsuyoshi, N., Miyachi, Y., Nakahata, T. (2004) Development of both human connective tissue-type and mucosal-type mast cells in mice from hematopoietic stem cells with identical distribution pattern to human body. Blood 103, 860–867.
6. Kitamura, Y., Fujita, J. (1989) Regulation of mast cell differentiation. BioEssays 10, 193–196.
7. Galli, S. J., Nakae, S., Tsai, M. (2005) Mast cells in the development of adaptive immune responses. Nat. Immunol. 6, 135–142.
8. McClain, D. E., Donlon, M. A., Chock, S., Catravas, G. N. (1983) The effect of calmodulin on histamine release in the rat peritoneal mast cell. Biochim. Biophys. Acta 763, 419–425.
9. Wang, X. S., Lau, H. Y. (2007) Histamine release from human buffy coat-derived mast cells. Int. Immunopharmacol. 7, 541–546.
10. Thurmond, R. L., Gelfand, E. W., Dunford, P. J. (2008) The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat. Rev. Drug Discov. 7, 41–53.
11. Ishihara, K., Murata, M., Kaneniwa, M., Saito, H., Shinohara, K., Maeda-Yamamoto, M., Kawasaki, K., Ooizumi, T. (1998) Effect of tetracosahexaenoic acid on the content and release of histamine, and eicosanoid production in MC/9 mouse mast cell. Lipids 33, 1107–1114.
12. Ringvall, M., Rönnberg, E., Wernersson, S., Duelli, A., Henningsson, F., Abrink, M., García-Faroldi, G., Fajardo, I., Pejler, G. (2008) Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan. J. Allergy Clin. Immunol. 121, 1020–1026.
13. Kushnir-Sukhov, N. M., Brown, J. M., Wu, Y., Kirshenbaum, A., Metcalfe, D. D. (2007) Human mast cells are capable of serotonin synthesis and release. J. Allergy Clin. Immunol. 119, 498–499.
14. Curzon, G. (1990) Serotonin and appetite. Ann. N. Y. Acad. Sci. 600, 521–530.
15. Lee, J. Y., Lee, M. Y., Chung, S. M., Chung, J. H. (1998) Chemically induced platelet lysis causes vasoconstriction by release of serotonin. Toxicol. Appl. Pharmacol. 149, 235–242.
16. Sommer, C. (2004) Serotonin in pain and analgesia: actions in the periphery. Mol. Neurobiol. 30, 117–125.
17. Lindstedt, K. A., Kokkonen, J. O., Kovanen, P. T. (1992) Soluble heparin proteoglycans released from stimulated mast cells induce uptake of low density lipoproteins by macrophages via scavenger receptor-mediated phagocytosis. J. Lipid Res. 33, 65–75.
18. Craig, S. S., Irani, A. M., Metcalfe, D. D., Schwartz, L. B. (1993) Ultrastructural localization of heparin to human mast cells of the MCTC and MCT types by labeling with antithrombin III-gold. Lab Invest 69, 552-561.
19. Otsuka, A., Kubo, M., Honda, T., Egawa, G., Nakajima, S., Tanizaki, H., Kim, B., Matsuoka, S., Watanabe, T., Nakae, S., Miyachi, Y., Kabashima, K. (2011) Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity. PLoS ONE 6, e25538.
20. Gray, E., Hogwood, J., Mulloy, B. (2012) The anticoagulant and antithrombotic mechanisms of heparin. Handbook Exp. Pharmacol. (207): 43–61.
21. Schwartz, L. B. (1990) Tryptase, a mediator of human mast cells. J. Allergy Clin. Immunol. 86, 594–598.
22. Valchanov, K. P. and Proctor, G. B. (1999) Enzyme histochemistry of tryptase in stomach mucosal mast cells of the mouse. J Histochem Cytochem 47, 617–522.
23. Caughey, G. H. (2007) Mast cell tryptases and chymases in inflammation and host defense. Immunol. Rev. 217, 141–154.
24. Walls, A. F., Brain, S. D., Desai, A., Jose, P. J., Hawkings, E., Church, M. K., Williams, T. J. (1992) Human mast cell tryptase attenuates the vasodilator activity of calcitonin gene-related peptide. Biochem. Pharmacol. 43, 1243–1248.
25. Imamura, T., Dubin, A., Moore, W., Tanaka, R., Travis, J. (1996) Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab Invest 74, 861–870.
26. Craig, S. S., Schwartz, L. B. (1989) Tryptase and chymase, markers of distinct types of human mast cells. Immunol. Res. 8, 130–148.
27. Brown, J. K., Knight, P. A., Wright, S. H., Thornton, E. M., Miller, H. R. (2003) Constitutive secretion of the granule chymase mouse mast cell protease-1 and the chemokine, CCL2, by mucosal mast cell homologues. Clin Exp Allergy 33, 132–146.
28. Leskinen, M., Wang, Y., Leszczynski, D., Lindstedt, K. A., Kovanen, P. T. (2001) Mast cell chymase induces apoptosis of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 21, 516–522.
29. Groschwitz, K. R., Wu, D., Osterfeld, H., Ahrens, R., Hogan, S. P. (2013) Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G479–G489.
30. Butterfield, J. H., Weiler, D., Peterson, E. A., Gleich, G. J., Leiferman, K. M. (1990) Sequestration of eosinophil major basic protein in human mast cells. Lab Invest 62, 77–86.
31. Gundel, R. H., Letts, L. G., Gleich, G. J. (1991) Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J. Clin. Invest. 87, 1470–1473.
32. Furuta, G. T., Nieuwenhuis, E. E., Karhausen, J., Gleich, G., Blumberg, R. S., Lee, J. J., Ackerman, S. J. (2005) Eosinophils alter colonic epithelial barrier function: role for major basic protein. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G890–G897.
33. Serafin, W. E., Dayton, E. T., Gravallese, P. M., Austen, K. F., Stevens, R. L. (1987) Carboxypeptidase A in mouse mast cells. Identification, characterization, and use as a differentiation marker. J. Immunol. 139, 3771–3776.
34. Goldstein, S. M., Kaempfer, C. E., Kealey, J. T., Wintroub, B. U. (1989) Human mast cell carboxypeptidase. Purification and characterization. J. Clin. Invest. 83, 1630–1636.
35. Pejler, G., Knight, S. D., Henningsson, F., Wernersson, S. (2009) Novel insights into the biological function of mast cell carboxypeptidase A. Trends Immunol. 30, 401–408.
36. Lewis, R. A., Soter, N. A., Diamond, P. T., Austen, K. F., Oates, J. A., Roberts II, L. J. (1982) Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J. Immunol. 129, 1627–1631.
37. Noguchi, J., Kuroda, E., Yamashita, U. (2005) Strain difference of murine bone marrow-derived mast cell functions. J. Leukoc. Biol. 78, 605–611.
38. Coleman, R. A., Sheldrick, R. L. (1989) Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors. Br. J. Pharmacol. 96, 688–692.
39. Johnston, S. L., Freezer, N. J., Ritter, W., O’Toole, S., Howarth, P. H. (1995) Prostaglandin D2-induced bronchoconstriction is mediated only in part by the thromboxane prostanoid receptor. Eur. Respir. J. 8, 411–415.
40. Chen, Y., Perussia, B., Campbell, K. S. (2007) Prostaglandin D2 suppresses human NK cell function via signaling through D prostanoid receptor. J. Immunol. 179, 2766–2773.
41. Obata, T., Nagakura, T., Masaki, T., Maekawa, K., Yamashita, K. (1999) Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. Clin Exp Allergy 29, 1129–1135.
42. Marshall, J. S., Gomi, K., Blennerhassett, M. G., Bienenstock, J. (1999) Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. J. Immunol. 162, 4271–4276.
43. Ren, J., Karpinski, E., Benishin, C. G. (1995) Prostaglandin E2 contracts vascular smooth muscle and inhibits potassium currents in vascular smooth muscle cells of rat tail artery. J. Pharmacol. Exp. Ther. 275, 710–719.
44. Yau, L., Zahradka, P. (2003) PGE(2) stimulates vascular smooth muscle cell proliferation via the EP2 receptor. Mol. Cell. Endocrinol. 203, 77–90.
45. Kolaczkowska, E., Scislowska-Czarnecka, A., Chadzinska, M., Plytycz, B., van Rooijen, N., Opdenakker, G., Arnold, B. (2006) Enhanced early vascular permeability in gelatinase B (MMP-9)-deficient mice: putative contribution of COX-1-derived PGE2 of macrophage origin. J. Leukoc. Biol. 80, 125–132.
46. Gueck, T., Seidel, A., Baumann, D., Meister, A., Fuhrmann, H. (2004) Alterations of mast cell mediator production and release by gammalinolenic and docosahexaenoic acid. Vet. Dermatol. 15, 309–314.
47. Freeland, H. S., Schleimer, R. P., Schulman, E. S., Lichtenstein, L. M., Peters, S. P. (1988) Generation of leukotriene B4 by human lung fragments and purified human lung mast cells. Am. Rev. Respir. Dis. 138, 389–394.
48. Miyahara, N., Ohnishi, H., Miyahara, S., Takeda, K., Matsubara, S., Matsuda, H., Okamoto, M., Loader, J. E., Joetham, A., Tanimoto, M., Dakhama, A., Gelfand, E. W. (2009) Leukotriene B4 release from mast cells in IgE-mediated airway hyperresponsiveness and inflammation. Am. J. Respir. Cell Mol. Biol. 40, 672–682.
49. Bray, M. A., Cunningham, F. M., Ford-Hutchinson, A. W., Smith, M. J. (1981) Leukotriene B4: a mediator of vascular permeability. Br. J. Pharmacol. 72, 483–486.
50. Larkin, S. W., Fraser, L., Showell, H. J., Williams, T. J., Warren, J. B. (1995) Prolonged microvascular vasodilation induced by leukotriene B4 in human skin is cyclooxygenase independent. J. Pharmacol. Exp. Ther. 272, 392–398.
51. Saiwai, H., Ohkawa, Y., Yamada, H., Kumamaru, H., Harada, A., Okano, H., Yokomizo, T., Iwamoto, Y., Okada, S. (2010) The LTB4-BLT1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury. Am. J. Pathol. 176, 2352–2366.
52. Kuwamori, M., Wada, M., Takita, T., Tadokoro, T., Maekawa, A., Innami, S. (1997) Effect of dietary n-3/n-6 fatty acid ratio on the total count, fatty acid composition, and histamine and leukotriene concentrations of mast cells in tunica mucosa bronchiorum of type I allergic guinea pig. Biosci. Biotechnol. Biochem. 61, 763–767.
53. Razin, E., Mencia-Huerta, J. M., Lewis, R. A., Corey, E. J., Austen, K. F. (1982) Generation of leukotriene C4 from a subclass of mast cells differentiated in vitro from mouse bone marrow. Proc. Natl. Acad. Sci. USA 79, 4665–4667.
54. Bartosz, G., König, J., Keppler, D., Hagmann, W. (1998) Human mast cells secreting leukotriene C4 express the MRP1 gene-encoded conjugate export pump. Biol. Chem. 379, 1121–1126.
55. Bisgaard, H. (2001) Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma. Allergy 56(Suppl 66), 7–11.
56. Mencia-Huerta, J. M., Lewis, R. A., Razin, E., Austen, K. F. (1983) Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. J. Immunol. 131, 2958–2964.
57. Jeanneton, O., Delvaux, M., Botella, A., Frexinos, J., Bueno, L. (1993) Platelet-activating factor (PAF) induces a contraction of isolated smooth muscle cells from guinea pig ileum: intracellular pathway involved. J. Pharmacol. Exp. Ther. 267, 31–37.
58. Macconi, D., Foppolo, M., Paris, S., Noris, M., Aiello, S., Remuzzi, G., Remuzzi, A. (1995) PAF mediates neutrophil adhesion to thrombin or TNF-stimulated endothelial cells under shear stress. Am. J. Physiol. 269, C42–C47.
59. Clavijo, L. C., Carter, M. B., Matheson, P. J., Wilson, M. A., Wead, W. B., Garrison, R. N. (2001) PAF increases vascular permeability without increasing pulmonary arterial pressure in the rat. J Appl Physiol (1985) 90, 261–268.
60. Oksaharju, A., Lappalainen, J., Tuomainen, A. M., Pussinen, P. J., Puolakkainen, M., Kovanen, P. T., Lindstedt, K. A. (2009) Proatherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells. J. Cell. Mol. Med. 13, 103–113.
61. Hochdörfer, T., Tiedje, C., Stumpo, D. J., Blackshear, P. J., Gaestel, M., Huber, M. (2013) LPS-induced production of TNF-a and IL-6 in mast cells is dependent on p38 but independent of TTP. Cell. Signal. 25, 1339–1347.
62. Bradley, J. R. (2008) TNF-mediated inflammatory disease. J. Pathol. 214, 149–160.
63. Guma, M., Kashiwakura, J., Crain, B., Kawakami, Y., Beutler, B., Firestein, G. S., Kawakami, T., Karin, M., Corr, M. (2010) JNK1 controls mast cell degranulation and IL-1beta production in inflammatory arthritis. Proc. Natl. Acad. Sci. USA 107, 22122–22127.
64. Zhang, B., Asadi, S., Weng, Z., Sismanopoulos, N., Theoharides, T. C. (2012) Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions. PLoS ONE 7, e49767.
65. Ren, K., Torres, R. (2009) Role of interleukin-1beta during pain and inflammation. Brain Res. Brain Res. Rev. 60, 57–64.
66. Bradding, P., Feather, I. H., Howarth, P. H., Mueller, R., Roberts, J. A., Britten, K., Bews, J. P., Hunt, T. C., Okayama, Y., Heusser, C. H., et al. (1992) Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176, 1381–1386.
67. Sherman, M. A., Secor, V. H., Lee, S. K., Lopez, R. D., Brown, M. A. (1999) STAT6-independent production of IL-4 by mast cells. Eur. J. Immunol. 29, 1235–1242.
68. Luzina, I. G., Keegan, A. D., Heller, N. M., Rook, G. A., Shea-Donohue, T., Atamas, S. P. (2012) Regulation of inflammation by interleukin-4: a review of “alternatives”. J. Leukoc. Biol. 92, 753–764.
69. Park, B. K., Park, S., Park, J. B., Park, M. C., Min, T. S., Jin, M. (2013) Omega-3 fatty acids suppress Th2-associated cytokine gene expressions and GATA transcription factors in mast cells. J. Nutr. Biochem. 24, 868–876.
70. Lorentz, A., Schwengberg, S., Mierke, C., Manns, M. P., Bischoff, S. C. (1999) Human intestinal mast cells produce IL-5 in vitro upon IgE receptor cross-linking and in vivo in the course of intestinal inflammatory disease. Eur. J. Immunol. 29, 1496–1503.
71. Chiba, N., Masuda, A., Yoshikai, Y., Matsuguchi, T. (2007) Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells. J. Cell. Physiol. 213, 126–136.
72. Kouro, T., Takatsu, K. (2009) IL-5-and eosinophil-mediated inflammation: from discovery to therapy. Int. Immunol. 21, 1303–1309.
73. Kandere-Grzybowska, K., Kempuraj, D., Cao, J., Cetrulo, C. L., Theoharides, T. C. (2006) Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br. J. Pharmacol. 148, 208–215.
74. Scheller, J., Chalaris, A., Schmidt-Arras, D., Rose-John, S. (2011) The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 1813, 878–888.
75. Feoktistov, I., Biaggioni, I. (1995) Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells: an enprofylline-sensitive mechanism with implications for asthma. J. Clin. Invest. 96, 1979–1986.
76. Heidemann, J., Ogawa, H., Dwinell, M. B., Rafiee, P., Maaser, C., Gockel, H. R., Otterson, M. F., Ota, D. M., Lugering, N., Domschke, W., Binion, D. G. (2003) Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J. Biol. Chem. 278, 8508–8515.
77. Ishizuka, T., Okayama, Y., Kobayashi, H., Mori, M. (1999) Interleukin-10 is localized to and released by human lung mast cells. Clin Exp Allergy 29, 1424–1432.
78. Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., Hymowitz, S. G. (2011) Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29, 71–109.
79. Toru, H., Pawankar, R., Ra, C., Yata, J., Nakahata, T. (1998) Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells. J. Allergy Clin. Immunol. 102, 491–502.
80. Pope, S. M., Brandt, E. B., Mishra, A., Hogan, S. P., Zimmermann, N., Matthaei, K. I., Foster, P. S., Rothenberg, M. E. (2001) IL-13 induces eosinophil recruitment into the lung by an IL-5-and eotaxin-dependent mechanism. J. Allergy Clin. Immunol. 108, 594–601.
81. Chiba, Y., Nakazawa, S., Todoroki, M., Shinozaki, K., Sakai, H., Misawa, M. (2009) Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein. Am. J. Respir. Cell Mol. Biol. 40, 159–167.
82. Lin, A. M., Rubin, C. J., Khandpur, R., Wang, J. Y., Riblett, M., Yalavarthi, S., Villanueva, E. C., Shah, P., Kaplan, M. J., Bruce, A. T. (2011) Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J. Immunol. 187, 490–500.
83. Miossec, P., Kolls, J. K. (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11, 763–776.
84. Hsu, C. L., Neilsen, C. V., Bryce, P. J. (2010) IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One 5, e11944.
85. Schiering, C., Krausgruber, T., Chomka, A., Fröhlich, A., Adelmann, K., Wohlfert, E. A., Pott, J., Griseri, T., Bollrath, J., Hegazy, A. N., Harrison, O. J., Owens, B. M., Löhning, M., Belkaid, Y., Fallon, P. G., Powrie, F. (2014) The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564–568.
86. Gupta, A. A., Leal-Berumen, I., Croitoru, K., Marshall, J. S. (1996) Rat peritoneal mast cells produce IFN-gamma following IL-12 treatment but not in response to IgE-mediated activation. J. Immunol. 157, 2123–2128.
87. Schroder, K., Hertzog, P. J., Ravasi, T., Hume, D. A. (2004) Interferongamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75, 163–189.
88. Kanbe, N., Kurosawa, M., Nagata, H., Saitoh, H., Miyachi, Y. (1999) Cord blood-derived human cultured mast cells produce transforming growth factor beta1. Clin Exp Allergy 29, 105–113.
89. Taylor, A. W. (2009) Review of the activation of TGF-beta in immunity. J. Leukoc. Biol. 85, 29–33.
90. Hogaboam, C., Kunkel, S. L., Strieter, R. M., Taub, D. D., Lincoln, P., Standiford, T. J., Lukacs, N. W. (1998) Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cellfibroblast interactions. J. Immunol. 160, 6166–6171.
91. Menzies-Gow, A., Ying, S., Sabroe, I., Stubbs, V. L., Soler, D., Williams, T. J., Kay, A. B. (2002) Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early-and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J. Immunol. 169, 2712–2718.
92. Venkatesha, R. T., Berla Thangam, E., Zaidi, A. K., Ali, H. (2005) Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol. Immunol. 42, 581–587.
93. Toda, M., Kuo, C. H., Borman, S. K., Richardson, R. M., Inoko, A., Inagaki, M., Collins, A., Schneider, K., Ono, S. J. (2012) Evidence that formation of vimentin mitogen-activated protein kinase (MAPK) complex mediates mast cell activation following Fc«RI/CC chemokine receptor 1 cross-talk. J. Biol. Chem. 287, 24516–24524.
94. Gaga, M., Ong, Y. E., Benyahia, F., Aizen, M., Barkans, J., Kay, A. B. (2008) Skin reactivity and local cell recruitment in human atopic and nonatopic subjects by CCL2/MCP-1 and CCL3/MIP-1alpha. Allergy 63, 703–711.
95. Qian, B. Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., Pollard, J. W. (2011) CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475, 222–225.
96. Schuh, J. M., Blease, K., Brühl, H., Mack, M., Hogaboam, C. M. (2003) Intrapulmonary targeting of RANTES/CCL5-responsive cells prevents chronic fungal asthma. Eur. J. Immunol. 33, 3080–3090.
97. Keophiphath, M., Rouault, C., Divoux, A., Clément, K., Lacasa, D. (2010) CCL5 promotes macrophage recruitment and survival in human adipose tissue. Arterioscler. Thromb. Vasc. Biol. 30, 39–45.
98. De Filippo, K., Dudeck, A., Hasenberg, M., Nye, E., van Rooijen, N., Hartmann, K., Gunzer, M., Roers, A., Hogg, N. (2013) Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 121, 4930–4937.
99. Zhang, S., Anderson, D. F., Bradding, P., Coward, W. R., Baddeley, S. M., MacLeod, J. D., McGill, J. I., Church, M. K., Holgate, S. T., Roche, W. R. (1998) Human mast cells express stem cell factor. J. Pathol. 186, 59–66.
100. Lennartsson, J., Rönnstrand, L. (2012) Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol. Rev. 92, 1619–1649.
101. Sismanopoulos, N., Delivanis, D. A., Alysandratos, K. D., Angelidou, A., Vasiadi, M., Therianou, A., Theoharides, T. C. (2012) IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis. PLoS One 7, e33271.
102. Jimenez-Andrade, G. Y., Ibarra-Sanchez, A., Gonzalez, D., Lamas, M., Gonzalez-Espinosa, C. (2013) Immunoglobulin E induces VEGF production in mast cells and potentiates their pro-tumorigenic actions through a Fyn kinase-dependent mechanism. J Hematol Oncol 6, 56.
103. Liang, D., Chang, J. R., Chin, A. J., Smith, A., Kelly, C., Weinberg, E. S., Ge, R. (2001) The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development. Mech. Dev. 108, 29–43.
104. Leon, A., Buriani, A., Dal Toso, R., Fabris, M., Romanello, S., Aloe, L., Levi-Montalcini, R. (1994) Mast cells synthesize, store, and release nerve growth factor. Proc. Natl. Acad. Sci. USA 91, 3739–3743.
105. Nilsson, G., Forsberg-Nilsson, K., Xiang, Z., Hallböök, F., Nilsson, K., Metcalfe, D. D. (1997) Human mast cells express functional TrkA and are a source of nerve growth factor. Eur. J. Immunol. 27, 2295–2301.
106. Xiang, Z. and Nilsson, G. (2000) IgE receptor-mediated release of nerve growth factor by mast cells. Clin Exp Allergy 30, 1379–1386.
107. Sofroniew, M. V., Howe, C. L., Mobley, W. C. (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24, 1217–1281.
108. van Steensel, L., Paridaens, D., van Meurs, M., van Hagen, P. M., van den Bosch, W. A., Kuijpers, R. W., Drexhage, H. A., Hooijkaas, H., Dik, W. A. (2012) Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 97, E400–E408.
109. Andrae, J., Gallini, R., Betsholtz, C. (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 22, 1276–1312.
110. Swindle, E. J., Metcalfe, D. D., Coleman, J. W. (2004) Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide. J. Biol. Chem. 279, 48751–48759.
111. Sena, L. A., Chandel, N. S. (2012) Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 48, 158–167.
112. van den Elsen, L. W., Nusse, Y., Balvers, M., Redegeld, F. A., Knol, E. F., Garssen, J., Willemsen, L. E. (2013) n-3 Long-chain PUFA reduce allergy-related mediator release by human mast cells in vitro via inhibition of reactive oxygen species. Br. J. Nutr. 109, 1821–1831.
113. Kempuraj, D., Papadopoulou, N. G., Lytinas, M., Huang, M., Kandere-Grzybowska, K., Madhappan, B., Boucher, W., Christodoulou, S., Athanassiou, A., Theoharides, T. C. (2004) Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology 145, 43–48.
114. Parkes, D. G., May, C. N. (2000) Urocortin: a novel player in cardiac control. News Physiol Sci 15, 264-268.
115. Kalesnikoff, J., Galli, S. J. (2008) New developments in mast cell biology. Nat. Immunol. 9, 1215–1223.
116. Hofmann, A. M., Abraham, S. N. (2009) New roles for mast cells in modulating allergic reactions and immunity against pathogens. Curr. Opin. Immunol. 21, 679–686.
117. Stelekati, E., Orinska, Z., Bulfone-Paus, S. (2007) Mast cells in allergy: innate instructors of adaptive responses. Immunobiology 212, 505–519.
118. Bot, I., van Berkel, T. J., Biessen, E. A. (2008) Mast cells: pivotal players in cardiovascular diseases. Curr. Cardiol. Rev. 4, 170–178.
119. Galli, S. J., Tsai, M., Wershil, B. K., Tam, S. Y., Costa, J. J. (1995) Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor. Int. Arch. Allergy Immunol. 107, 51–53.
120. Alderton, G. K. (2012) Signalling: new roles for TLR2. Nat. Rev. Immunol. 12, 810–811.
121. Antohe, F., Dobrila, L. N., Heltianu, C. (1988) Histamine receptor on mast cells. Microcirc. Endothelium Lymphatics 4, 469–488.
122. Hofstra, C. L., Desai, P. J., Thurmond, R. L., Fung-Leung, W. P. (2003) Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 305, 1212–1221.
123. Jiang, Y., Borrelli, L. A., Kanaoka, Y., Bacskai, B. J., Boyce, J. A. (2007) CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells. Blood 110, 3263–3270.
124. el-Lati, S. G., Dahinden, C. A., Church, M. K. (1994) Complement peptides C3a-and C5a-induced mediator release from dissociated human skin mast cells. J. Invest. Dermatol. 102, 803–806.
125. Füreder, W., Agis, H., Willheim, M., Bankl, H. C., Maier, U., Kishi, K., Müller, M. R., Czerwenka, K., Radaszkiewicz, T., Butterfield, J. H., Klappacher, G. W., Sperr, W. R., Oppermann, M., Lechner, K., Valent, P. (1995) Differential expression of complement receptors on human basophils and mast cells: evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J. Immunol. 155, 3152–3160.
126. Andrásfalvy, M., Prechl, J., Hardy, T., Erdei, A., Bajtay, Z. (2002) Mucosal type mast cells express complement receptor type 2 (CD21). Immunol. Lett. 82, 29–34.
127. Kajiwara, N., Sasaki, T., Bradding, P., Cruse, G., Sagara, H., Ohmori, K., Saito, H., Ra, C., Okayama, Y. (2010) Activation of human mast cells through the platelet-activating factor receptor. J Allergy Clin Immunol 125, 1137–1145.
128. Bulanova, E., Budagian, V., Orinska, Z., Hein, M., Petersen, F., Thon, L., Adam, D., Bulfone-Paus, S. (2005) Extracellular ATP induces cytokine expression and apoptosis through P2X7 receptor in murine mast cells. J. Immunol. 174, 3880–3890.
129. Tang, H. B., Li, Y. S., Arihiro, K., Nakata, Y. (2007) Activation of the neurokinin-1 receptor by substance P triggers the release of substance P from cultured adult rat dorsal root ganglion neurons. Mol. Pain 3, 42.
130. Pundir, P., Catalli, A., Leggiadro, C., Douglas, S. E., Kulka, M. (2014) Pleurocidin, a novel antimicrobial peptide, induces human mast cell activation through the FPRL1 receptor. Mucosal Immunol. 7, 177–187.
131. Sheen, C. H., Schleimer, R. P., Kulka, M. (2007) Codeine induces human mast cell chemokine and cytokine production: involvement of G-protein activation. Allergy 62, 532–538.
132. Kulka, M., Sheen, C. H., Tancowny, B. P., Grammer, L. C., Schleimer, R. P. (2008) Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 123, 398–410.
133. Kulka, M., Fukuishi, N., Rottem, M., Mekori, Y. A., Metcalfe, D. D. (2006) Mast cells, which interact with Escherichia coli, up-regulate genes associated with innate immunity and become less responsive to Fc (epsilon)RI-mediated activation. J. Leukoc. Biol. 79, 339–350.
134. Kirshenbaum, A. S., Swindle, E., Kulka, M., Wu, Y., Metcalfe, D. D. (2008) Effect of lipopolysaccharide (LPS) and peptidoglycan (PGN) on human mast cell numbers, cytokine production, and protease composition. BMC Immunol. 9, 45.
135. McCary, C., Tancowny, B. P., Catalli, A., Grammer, L. C., Harris, K. E., Schleimer, R. P., Kulka, M. (2010) Substance P down-regulates expression of the high affinity IgE receptor (FcepsilonRI) by human mast cells. J. Neuroimmunol. 220, 17–24.
136. Calder, P. C. (2013) Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br. J. Clin. Pharmacol. 75, 645–662.
137. Su, K. P. (2008) Mind-body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression. Asia Pac. J. Clin. Nutr. 17(Suppl 1), 151–157.
138. Umeda-Sawada, R., Fujiwara, Y., Ushiyama, I., Sagawa, S., Morimitsu, Y., Kawashima, H., Ono, Y., Kiso, Y., Matsumoto, A., Seyama, Y. (2006) Distribution and metabolism of dihomo-gamma-linolenic acid (DGLA, 20:3n-6) by oral supplementation in rats. Biosci. Biotechnol. Biochem. 70, 2121–2130.
139. Harel, Z., Riggs, S., Vaz, R., White, L., Menzies, G. (2001) n-3 polyunsaturated fatty acids in adolescents: knowledge and consumption. J Adolesc Health 28, 10–15.
140. Deckelbaum, R. J., Torrejon, C. (2012) The omega-3 fatty acid nutritional landscape: health benefits and sources. J. Nutr. 142, 587S–591S.
141. Siriwardhana, N., Kalupahana, N. S., Moustaid-Moussa, N. (2012) Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Adv. Food Nutr. Res. 65, 211–222.
142. Dewailly, E., Blanchet, C., Lemieux, S., Sauvé, L., Gingras, S., Ayotte, P., Holub, B. J. (2001) n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am. J. Clin. Nutr. 74, 464–473.
143. Dyerberg, J., Bang, H. O., Stoffersen, E., Moncada, S., Vane, J. R. (1978) Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2, 117–119.
144. Holub, B. J. (1988) Dietary fish oils containing eicosapentaenoic acid and the prevention of atherosclerosis and thrombosis. Can Med Assoc J 139, 377–381.
145. Wang, X., Breeze, A., Kulka, M. (2015) n-3 polyunsaturated fatty acids inhibit IFN-gamma-induced IL-18 binding protein production by prostate cancer cells. Cancer Immunol. Immunother. 64, 249–258.
146. Calder, P. C. (1997) n-3 polyunsaturated fatty acids and immune cell function. Adv. Enzyme Regul. 37, 197–237.
147. Wu, D., Meydani, S. N. (1998) n-3 Polyunsaturated fatty acids and immune function. Proc. Nutr. Soc. 57, 503–509.
148. de Matos, O. G., Amaral, S. S., Pereira da Silva, P. E., Perez, D. A., Alvarenga, D. M., Ferreira, A. V., Alvarez-Leite, J., Menezes, G. B., Cara, D. C. (2012) Dietary supplementation with omega-3-PUFA-rich fish oil reduces signs of food allergy in ovalbumin-sensitized mice. Clin. Dev. Immunol. 2012, 236564.
149. Bilal, S., Haworth, O., Wu, L., Weylandt, K. H., Levy, B. D., Kang, J. X. (2011) Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses. Biochim. Biophys. Acta 1812, 1164–1169.
150. Jang, H. Y., Lim, K., Lee, S. M., Park, B. H. (2014) Effects of n-3 PUFA on the CD4+ type 2 helper T-cell-mediated immune responses in Fat-1 mice. Mol. Nutr. Food Res. 58, 365–375.
151. Oddy, W. H., de Klerk, N. H., Kendall, G. E., Mihrshahi, S., Peat, J. K. (2004) Ratio of omega-6 to omega-3 fatty acids and childhood asthma. J Asthma 41, 319–326.
152. Laerum, B. N., Wentzel-Larsen, T., Gulsvik, A., Omenaas, E., Gislason, T., Janson, C., Svanes, C. (2007) Relationship of fish and cod oil intake with adult asthma. Clin Exp Allergy 37, 1616–1623.
153. Schubert, R., Kitz, R., Beermann, C., Rose, M. A., Lieb, A., Sommerer, P. C., Moskovits, J., Alberternst, H., Böhles, H. J., Schulze, J., Zielen, S. (2009) Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge. Int. Arch. Allergy Immunol. 148, 321–329.
154. Paolini, R., Jouvin, M. H., Kinet, J. P. (1991) Phosphorylation and dephosphorylation of the high-affinity receptor for immunoglobulin E immediately after receptor engagement and disengagement. Nature 353, 855–858.
155. Andrews, N. L., Pfeiffer, J. R., Martinez, A. M., Haaland, D. M., Davis, R. W., Kawakami, T., Oliver, J. M., Wilson, B. S., Lidke, D. S. (2009) Small, mobile FcepsilonRI receptor aggregates are signaling competent. Immunity 31, 469–479.
156. Ra, C., Nunomura, S., Okayama, Y. (2012) Fine-tuning of mast cell activation by FcεRIβ chain. Front. Immunol. 3, 112.
157. Taube, C., Wei, X., Swasey, C. H., Joetham, A., Zarini, S., Lively, T., Takeda, K., Loader, J., Miyahara, N., Kodama, T., Shultz, L. D., Donaldson, D. D., Hamelmann, E. H., Dakhama, A., Gelfand, E. W. (2004) Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J. Immunol. 172, 6398–6406.
158. Bugajev, V., Bambousková, M., Dráberová, L., Dráber, P. (2010) What precedes the initial tyrosine phosphorylation of the high affinity IgE receptor in antigen-activated mast cell? FEBS Lett. 584, 4949–4955.
159. Kawasaki, M., Toyoda, M., Teshima, R., Sawada, J., Saito, Y. (1994) Effect of alpha-linolenic acid on the metabolism of omega-3 and omega-6 polyunsaturated fatty acids and histamine release in RBL-2H3 cells. Biol. Pharm. Bull. 17, 1321–1325.
160. Gueck, T., Seidel, A., Fuhrmann, H. (2003) Effects of essential fatty acids on mediators of mast cells in culture. Prostaglandins Leukot. Essent. Fatty Acids 68, 317–322.
161. van Haaster, C. M., Engels, W., Lemmens, P. J., Hornstra, G., van der Vusse, G. J. (1993) Formation of prostanoids and hydroxy fatty acids by stimulated peritoneal mast cells: role of the dietary fat type in rat. Biochim. Biophys. Acta 1167, 147–154.
162. Nakano, N., Nakao, A., Uchida, T., Shirasaka, N., Yoshizumi, H., Okumura, K., Tsuboi, R., Ogawa, H. (2005) Effects of arachidonic acid analogs on FcepsilonRI-mediated activation of mast cells. Biochim. Biophys. Acta 1738, 19–28.
163. Froese, A., Helm, R. M., Conrad, D. H., Isersky, C., Ishizaka, T., Kulczycki, A., Jr. (1982) Comparison of the receptors for IgE of various rat basophilic leukaemia cell lines. I. Receptors isolated by IgESepharose and IgE and anti-IgE. Immunology 46, 107–116.
164. Passante, E., Ehrhardt, C., Sheridan, H., Frankish, N. (2009) RBL-2H3 cells are an imprecise model for mast cell mediator release. Inflamm Res 58, 611–618.
165. Gueck, T., Seidel, A., Fuhrmann, H. (2004) Consequences of eicosapentaenoic acid (n-3) and arachidonic acid (n-6) supplementation on mast cell mediators. J. Anim. Physiol. Anim. Nutr. (Berl.) 88, 259–265.
166. Lingwood, D., Simons, K. (2010) Lipid rafts as a membrane-organizing principle. Science 327, 46–50.
167. Waugh, M. G. (2013) Raft-like membranes from the trans-Golgi network and endosomal compartments. Nat. Protoc. 8, 2429–2439.
168. Young, R. M., Zheng, X., Holowka, D., Baird, B. (2005) Reconstitution of regulated phosphorylation of FcepsilonRI by a lipid raft-excluded protein-tyrosine phosphatase. J. Biol. Chem. 280, 1230–1235.
169. Simons, K., Sampaio, J. L. (2011) Membrane organization and lipid rafts. Cold Spring Harb. Perspect. Biol. 3, a004697.
170. Silveira E Souza, A. M., Mazucato, V. M., Jamur, M. C., Oliver, C. (2011) Lipid rafts in mast cell biology. J. Lipids 2011, 752906.
171. Silveira e Souza, A. M., Trindade, E. S., Jamur, M. C., Oliver, C. (2010) Gangliosides are important for the preservation of the structure and organization of RBL-2H3 mast cells. J Histochem Cytochem 58, 83–93.
172. Gao, H., Shi, W., Freund, L. B. (2005) Mechanics of receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA 102, 9469–9474.
173. Lafont, F., Simons, K. (2001) Raft-partitioning of the ubiquitin ligases Cbl and Nedd4 upon IgE-triggered cell signaling. Proc. Natl. Acad. Sci. USA 98, 3180–3184.
174. Fattakhova, G. V., Masilamani, M., Narayanan, S., Borrego, F., Gilfillan, A. M., Metcalfe, D. D., Coligan, J. E. (2009) Endosomal trafficking of the ligated FcvarepsilonRI receptor. Mol. Immunol. 46, 793–802.
175. Oliver, C., Fujimura, A., Silveira, E. S. A. M., Orlandini de Castro, R., Siraganian, R. P., Jamur, M. C. (2007) Mast cell-specific gangliosides and FcɛRI follow the same endocytic pathway from lipid rafts in RBL-2H3 cells. J Histochem Cytochem 55, 315–325.
176. Mazucato, V. M., Silveira, E. S. A. M., Nicoletti, L. M., Jamur, M. C., Oliver, C. (2011) GD1b-derived gangliosides modulate FcepsilonRI endocytosis in mast cells. J Histochem Cytochem 59, 428–440.
177. Simons, K., Toomre, D. (2000) Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1, 31–39.
178. Field, K. A., Holowka, D., Baird, B. (1997) Compartmentalized activation of the high affinity immunoglobulin E receptor within membrane domains. J. Biol. Chem. 272, 4276–4280.
179. Young, R. M., Holowka, D., Baird, B. (2003) A lipid raft environment enhances Lyn kinase activity by protecting the active site tyrosine from dephosphorylation. J. Biol. Chem. 278, 20746–20752.
180. Kato, N., Nakanishi, M., Hirashima, N. (2006) Flotillin-1 regulates IgE receptor-mediated signaling in rat basophilic leukemia (RBL-2H3) cells. J. Immunol. 177, 147–154.
181. Sheets, E. D., Holowka, D., Baird, B. (1999) Critical role for cholesterol in Lyn-mediated tyrosine phosphorylation of FcepsilonRI and their association with detergent-resistant membranes. J. Cell Biol. 145, 877–887.
182. Field, K. A., Apgar, J. R., Hong-Geller, E., Siraganian, R. P., Baird, B., Holowka, D. (2000) Mutant RBL mast cells defective in Fc epsilon RI signaling and lipid raft biosynthesis are reconstituted by activated Rhofamily GTPases. Mol. Biol. Cell 11, 3661–3673.
183. Jump, D. B. (2002) The biochemistry of n-3 polyunsaturated fatty acids. J. Biol. Chem. 277, 8755–8758.
184. Holthuis, J. C., Levine, T. P. (2005) Lipid traffic: floppy drives and a superhighway. Nat. Rev. Mol. Cell Biol. 6, 209–220.
185. Anderson, B. M., Ma, D. W. (2009) Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis. 8, 33.
186. Li, Q., Wang, M., Tan, L., Wang, C., Ma, J., Li, N., Li, Y., Xu, G., Li, J. (2005) Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts. J. Lipid Res. 46, 1904–1913.
187. Basiouni, S., Stöckel, K., Fuhrmann, H., Schumann, J. (2012) Polyunsaturated fatty acid supplements modulate mast cell membrane microdomain composition. Cell. Immunol. 275, 42–46.
188. Khanapure, S. P., Garvey, D. S., Janero, D. R., Letts, L. G. (2007) Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr. Top. Med. Chem. 7, 311–340.
189. Calder, P. C. (2010) n-3 fatty acids and inflammatory processes. Nutrients 2, 355–374.
190. Fan, C., Zirpoli, H., Qi, K. (2013) n-3 Fatty acids modulate adipose tissue inflammation and oxidative stress. Curr. Opin. Clin. Nutr. Metab. Care 16, 124–132.
191. Calder, P. C. (2006) n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 83 ((6): Suppl) 1505S–1519S.
192. Fregonese, L., Silvestri, M., Sabatini, F., Rossi, G. A. (2002) Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a CysLT1 receptor-mediated mechanism. Clin Exp Allergy 32, 745–750.
193. Hallstrand, T. S., Henderson, W. R., Jr. (2010) An update on the role of leukotrienes in asthma. Curr. Opin. Allergy Clin. Immunol. 10, 60–66.
194. Wang, X., Lin, H., Gu, Y. (2012) Multiple roles of dihomo-g-linolenic acid against proliferation diseases. Lipids Health Dis. 11, 25.
195. Yousefi, B., Darabi, M., Baradaran, B., Shekari Khaniani, M., Rahbani, M., Darabi, M., Fayezi, S., Mehdizadeh, A., Saliani, N., Shaaker, M. (2012) Inhibition of MEK/ERK1/2 signaling affects the fatty acid composition of HepG2 human hepatic cell line. BioImpacts 2, 145–1450.
196. Kelley, D. S., Bartolini, G. L., Newman, J. W., Vemuri, M., Mackey, B. E. (2006) Fatty acid composition of liver, adipose tissue, spleen, and heart of mice fed diets containing t10, c12-, and c9, t11-conjugated linoleic acid. Prostaglandins Leukot. Essent. Fatty Acids 74, 331–338.
197. de Roos, B., Mavrommatis, Y., Brouwer, I. A. (2009) Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br. J. Pharmacol. 158, 413–428.
198. Kohli, P., Levy, B. D. (2009) Resolvins and protectins: mediating solutions to inflammation. Br. J. Pharmacol. 158, 960–971.
199. Varga, T., Czimmerer, Z., Nagy, L. (2011) PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim. Biophys. Acta 1812, 1007–1022.
200. Sugiyama, H., Nonaka, T., Kishimoto, T., Komoriya, K., Tsuji, K., Nakahata, T. (2000) Peroxisome proliferator-activated receptors are expressed in human cultured mast cells: a possible role of these receptors in negative regulation of mast cell activation. Eur. J. Immunol. 30, 3363–3370.
201. Tachibana, M., Wada, K., Katayama, K., Kamisaki, Y., Maeyama, K., Kadowaki, T., Blumberg, R. S., Nakajima, A. (2008) Activation of peroxisome proliferator-activated receptor gamma suppresses mast cell maturation involved in allergic diseases. Allergy 63, 1136–1147.
202. Remels, A. H., Langen, R. C., Gosker, H. R., Russell, A. P., Spaapen, F., Voncken, J. W., Schrauwen, P., Schols, A. M. (2009) PPARgamma inhibits NF-kappaB-dependent transcriptional activation in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 297, E174–E183.
203. Lawrence, T. (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol. 1, a001651.
204. Fujita, T., Matsuoka, T., Honda, T., Kabashima, K., Hirata, T., Narumiya, S. (2011) A GPR40 agonist GW9508 suppresses CCL5, CCL17, and CXCL10 induction in keratinocytes and attenuates cutaneous immune inflammation. J. Invest. Dermatol. 131, 1660–1667.
205. Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., Olefsky, J. M. (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687–698.
206. Kuehn, H. S., Gilfillan, A. M. (2007) G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation. Immunol. Lett. 113, 59–69.